ID

21504

Beschreibung

Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00416312

Link

https://clinicaltrials.gov/show/NCT00416312

Stichworte

Versionen (1)
  1. 25.04.17 25.04.17 -
Hochgeladen am

25. April 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Lymphoma NCT00416312

Englisch

Eligibility Lymphoma NCT00416312

1 Formulare  
  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT00416312
Criteria
Beschreibung

Criteria

diagnosis of non-hodgkin's lymphoma
Beschreibung

Lymphoma, Non-Hodgkin

Datentyp

boolean

Alias
UMLS CUI [1]
C0024305
measurable disease by ct scan or nuclear medicine imaging
Beschreibung

Measurable Disease X-Ray Computed Tomography | Measurable Disease Radionuclide Imaging

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C0040405
UMLS CUI [2,1]
C1513041
UMLS CUI [2,2]
C0034606
eligible, by standard of care criteria, for iodine i 131 tositumomab or yttrium y 90 ibritumomab tiuxetan treatment
Beschreibung

Standard of Care criteria | Iodine-131 [I-131] tositumomab | yttrium-90-ibritumomab tiuxetan

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2936643
UMLS CUI [1,2]
C0243161
UMLS CUI [2]
C1260363
UMLS CUI [3]
C1134535
patient characteristics:
Beschreibung

Client Characteristics

Datentyp

boolean

Alias
UMLS CUI [1]
C0815172
no other malignancy within the past 3 years except basal cell carcinoma or squamous cell carcinoma of the skin or in situ carcinoma of the cervix
Beschreibung

Malignant Neoplasms Absent | Basal cell carcinoma | Squamous cell carcinoma of skin | Carcinoma in situ of uterine cervix

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0332197
UMLS CUI [2]
C0007117
UMLS CUI [3]
C0553723
UMLS CUI [4]
C0851140
not pregnant or nursing
Beschreibung

Pregnancy Absent | Breast Feeding Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0006147
UMLS CUI [2,2]
C0332197
fertile patients must use effective contraception
Beschreibung

Fertility Contraceptive methods

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0015895
UMLS CUI [1,2]
C0700589
no alcoholism or drug abuse within the past 2 years
Beschreibung

Chronic Alcoholic Intoxication Absent | Drug abuse Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0001973
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0013146
UMLS CUI [2,2]
C0332197
no severe emotional, behavioral, or psychiatric problems that would limit study compliance
Beschreibung

Emotional problems Severe Absent | Behaviorial problem Severe Absent | Psychiatric problem Severe Absent | Mental problem Protocol Compliance Limited

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0677660
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C0332197
UMLS CUI [2,1]
C0233514
UMLS CUI [2,2]
C0205082
UMLS CUI [2,3]
C0332197
UMLS CUI [3,1]
C1306597
UMLS CUI [3,2]
C0205082
UMLS CUI [3,3]
C0332197
UMLS CUI [4,1]
C0848067
UMLS CUI [4,2]
C0525058
UMLS CUI [4,3]
C0439801
prior concurrent therapy:
Beschreibung

Therapeutic procedure

Datentyp

boolean

Alias
UMLS CUI [1]
C0087111
no concurrent participation in another investigational drug study
Beschreibung

Study Subject Participation Status Exclusion | Investigational New Drugs Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2348568
UMLS CUI [1,2]
C2828389
UMLS CUI [2,1]
C0013230
UMLS CUI [2,2]
C0332197
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Lymphoma NCT00416312

1 Formulare
  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT00416312
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Lymphoma, Non-Hodgkin
Item
diagnosis of non-hodgkin's lymphoma
boolean
C0024305 (UMLS CUI [1])
Measurable Disease X-Ray Computed Tomography | Measurable Disease Radionuclide Imaging
Item
measurable disease by ct scan or nuclear medicine imaging
boolean
C1513041 (UMLS CUI [1,1])
C0040405 (UMLS CUI [1,2])
C1513041 (UMLS CUI [2,1])
C0034606 (UMLS CUI [2,2])
Standard of Care criteria | Iodine-131 [I-131] tositumomab | yttrium-90-ibritumomab tiuxetan
Item
eligible, by standard of care criteria, for iodine i 131 tositumomab or yttrium y 90 ibritumomab tiuxetan treatment
boolean
C2936643 (UMLS CUI [1,1])
C0243161 (UMLS CUI [1,2])
C1260363 (UMLS CUI [2])
C1134535 (UMLS CUI [3])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
Malignant Neoplasms Absent | Basal cell carcinoma | Squamous cell carcinoma of skin | Carcinoma in situ of uterine cervix
Item
no other malignancy within the past 3 years except basal cell carcinoma or squamous cell carcinoma of the skin or in situ carcinoma of the cervix
boolean
C0006826 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0007117 (UMLS CUI [2])
C0553723 (UMLS CUI [3])
C0851140 (UMLS CUI [4])
Pregnancy Absent | Breast Feeding Absent
Item
not pregnant or nursing
boolean
C0032961 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Fertility Contraceptive methods
Item
fertile patients must use effective contraception
boolean
C0015895 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Chronic Alcoholic Intoxication Absent | Drug abuse Absent
Item
no alcoholism or drug abuse within the past 2 years
boolean
C0001973 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0013146 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Emotional problems Severe Absent | Behaviorial problem Severe Absent | Psychiatric problem Severe Absent | Mental problem Protocol Compliance Limited
Item
no severe emotional, behavioral, or psychiatric problems that would limit study compliance
boolean
C0677660 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0233514 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C1306597 (UMLS CUI [3,1])
C0205082 (UMLS CUI [3,2])
C0332197 (UMLS CUI [3,3])
C0848067 (UMLS CUI [4,1])
C0525058 (UMLS CUI [4,2])
C0439801 (UMLS CUI [4,3])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
Study Subject Participation Status Exclusion | Investigational New Drugs Absent
Item
no concurrent participation in another investigational drug study
boolean
C2348568 (UMLS CUI [1,1])
C2828389 (UMLS CUI [1,2])
C0013230 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video